| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 47.894 | 93.557 | 66.018 | 85.976 | 78.043 | 56.555 | 51.168 |
| Total Income - EUR | - | - | 0 | 55.459 | 130.580 | 71.291 | 85.976 | 78.043 | 56.556 | 51.168 |
| Total Expenses - EUR | - | - | 4.409 | 39.951 | 43.056 | 42.437 | 54.142 | 49.519 | 46.427 | 46.729 |
| Gross Profit/Loss - EUR | - | - | -4.409 | 15.508 | 87.523 | 28.854 | 31.835 | 28.524 | 10.129 | 4.440 |
| Net Profit/Loss - EUR | - | - | -4.409 | 15.029 | 86.583 | 28.461 | 30.992 | 27.759 | 9.648 | 2.933 |
| Employees | - | - | 1 | 3 | 3 | 3 | 3 | 3 | 1 | 1 |
Check the financial reports for the company - Neogyn4M S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 51.205 | 43.387 | 36.320 | 29.523 | 23.468 | 17.285 | 10.995 | 4.950 |
| Current Assets | - | - | 5.064 | 5.226 | 63.034 | 2.082 | 12.703 | 36.219 | 6.315 | 5.894 |
| Inventories | - | - | 0 | 0 | 0 | 153 | 385 | 386 | 385 | 383 |
| Receivables | - | - | 0 | 967 | 0 | 29 | 0 | 23.684 | 3.550 | 4.542 |
| Cash | - | - | 5.064 | 4.259 | 63.034 | 1.900 | 12.318 | 12.149 | 2.380 | 970 |
| Shareholders Funds | - | - | -4.365 | 10.743 | 92.904 | 28.503 | 31.033 | 27.799 | 13.750 | 2.973 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 60.634 | 37.869 | 2.555 | 3.103 | 5.138 | 25.705 | 3.560 | 7.871 |
| Income in Advance | - | - | 0 | 0 | 3.896 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Neogyn4M S.r.l.